Tim Pastoor, PhD, DABT September 10, 2009 Assessing Cumulative Effects of Endocrine Active...
-
Upload
bartholomew-small -
Category
Documents
-
view
212 -
download
0
Transcript of Tim Pastoor, PhD, DABT September 10, 2009 Assessing Cumulative Effects of Endocrine Active...
![Page 1: Tim Pastoor, PhD, DABT September 10, 2009 Assessing Cumulative Effects of Endocrine Active Substances… or What happens when I’m exposed to a whole bunch.](https://reader035.fdocuments.in/reader035/viewer/2022070400/56649f0e5503460f94c22bb5/html5/thumbnails/1.jpg)
Tim Pastoor, PhD, DABT
September 10, 2009
Assessing Cumulative Effects of Endocrine Active Substances…
orWhat happens when I’m exposed to a whole bunch of endocrine active substances??
![Page 2: Tim Pastoor, PhD, DABT September 10, 2009 Assessing Cumulative Effects of Endocrine Active Substances… or What happens when I’m exposed to a whole bunch.](https://reader035.fdocuments.in/reader035/viewer/2022070400/56649f0e5503460f94c22bb5/html5/thumbnails/2.jpg)
2
Dioxin
Lindane
Methoxychlor
Toxaphene
Endrin
ChlordaneHeptaclor
Ethinylestradiol (EE)
Estrone
Coumestrol
Genistein
Daidzein
Isobutylparaben
Butylparaben
Tim Pastoor, PhD, DABT
![Page 3: Tim Pastoor, PhD, DABT September 10, 2009 Assessing Cumulative Effects of Endocrine Active Substances… or What happens when I’m exposed to a whole bunch.](https://reader035.fdocuments.in/reader035/viewer/2022070400/56649f0e5503460f94c22bb5/html5/thumbnails/3.jpg)
3
(From R. Golden)
Comparative Potency of Xenoestrogens in Rodent Uterotropic Assay
Substance
Effective dose(mg/kg/day)
Relative potencyEE=1,000,000
DES 0.0001 3,000,000
Ethinylestradiol (EE) 0.0003 1,000,000
Estrone 0.0012 250,000
Coumestrol 0.24 1250
Genistein 8 37
Daidzein 11 27
Isobutylparaben 73 4
Butylparaben 600 0.5
Benzylparaben 2500 0.12
Tim Pastoor, PhD, DABT
![Page 4: Tim Pastoor, PhD, DABT September 10, 2009 Assessing Cumulative Effects of Endocrine Active Substances… or What happens when I’m exposed to a whole bunch.](https://reader035.fdocuments.in/reader035/viewer/2022070400/56649f0e5503460f94c22bb5/html5/thumbnails/4.jpg)
4
Chemical MCL (mg/l) HypotheticalPotency (TEF)
Intake TEQ
Dioxin 0.00000003 0.000004 0.0000000012
Lindane 0.002 0.0038 0.00000152
Methoxychlor 0.04 0.000016 0.00000128
Atrazine 0.003 0.00005 0.0000003
PCBs 0.005 0.0000018 0.00000018
Toxaphene 0.003 0.008 0.000048
Simazine 0.1 0.0001 0.00002
Endrin 0.002 0.0009 0.000036
Chlordane 0.002 0.00001 0.000004
Heptaclor 0.0004 0.0003 0.000024
B(a)P 0.0002 0.0006 0.0000024
Total 0.00014
Hypothetical Illustration of TEF/TEQ Approach for WEEDs in Drinking Water
Tim Pastoor, PhD, DABT
![Page 5: Tim Pastoor, PhD, DABT September 10, 2009 Assessing Cumulative Effects of Endocrine Active Substances… or What happens when I’m exposed to a whole bunch.](https://reader035.fdocuments.in/reader035/viewer/2022070400/56649f0e5503460f94c22bb5/html5/thumbnails/5.jpg)
5
Receptor Terminology: Law of Mass Action
Drug + Receptor Drug-Receptor
ComplexResponse(s)
Tim Pastoor, PhD, DABT
• Affinity: the “tenacity” by which a drug binds to its receptor.
•Intrinsic activity: the relative maximal response caused by a drug in a tissue preparation.
•Intrinsic efficacy: a drug’s ability to affect a receptor and cause a biological response.
•Potency: the relative ability of a drug to cause a measured biological or functional change.
![Page 6: Tim Pastoor, PhD, DABT September 10, 2009 Assessing Cumulative Effects of Endocrine Active Substances… or What happens when I’m exposed to a whole bunch.](https://reader035.fdocuments.in/reader035/viewer/2022070400/56649f0e5503460f94c22bb5/html5/thumbnails/6.jpg)
6
The chain of events required for estrogen-induced uterine thickening
Tim Pastoor, PhD, DABT
Jonathan G. Moggs, et al. Phenotypic Anchoring of Gene Expression Changes during Estrogen-Induced Uterine Growth. Environ Health Perspect 112:1589–1606 (2004). doi:10.1289/txg.7345
![Page 7: Tim Pastoor, PhD, DABT September 10, 2009 Assessing Cumulative Effects of Endocrine Active Substances… or What happens when I’m exposed to a whole bunch.](https://reader035.fdocuments.in/reader035/viewer/2022070400/56649f0e5503460f94c22bb5/html5/thumbnails/7.jpg)
7
Time Course of Estrogen-Induced Uterine Growth
Tim Pastoor, PhD, DABT
Jonathan G. Moggs, et al. Phenotypic Anchoring of Gene Expression Changes during Estrogen-Induced Uterine Growth. Environ Health Perspect 112:1589–1606 (2004). doi:10.1289/txg.7345
![Page 8: Tim Pastoor, PhD, DABT September 10, 2009 Assessing Cumulative Effects of Endocrine Active Substances… or What happens when I’m exposed to a whole bunch.](https://reader035.fdocuments.in/reader035/viewer/2022070400/56649f0e5503460f94c22bb5/html5/thumbnails/8.jpg)
8
Receptor Terminology: Law of Mass Action
Drug + Receptor Drug-Receptor
ComplexResponse(s)
Tim Pastoor, PhD, DABT
• Affinity: the “tenacity” by which a drug binds to its receptor.
•Intrinsic activity: the relative maximal response caused by a drug in a tissue preparation.
•Intrinsic efficacy: a drug’s ability to affect a receptor and cause a biological response.
•Potency: the relative ability of a drug to cause a measured biological or functional change.
![Page 9: Tim Pastoor, PhD, DABT September 10, 2009 Assessing Cumulative Effects of Endocrine Active Substances… or What happens when I’m exposed to a whole bunch.](https://reader035.fdocuments.in/reader035/viewer/2022070400/56649f0e5503460f94c22bb5/html5/thumbnails/9.jpg)
9
Working Hypothesis:
Tim Pastoor, PhD, DABT
Can we state with reasonable certainty that a cumulative risk assessment of multiple week endocrine active substances is an exercise in adding zeroes??
![Page 10: Tim Pastoor, PhD, DABT September 10, 2009 Assessing Cumulative Effects of Endocrine Active Substances… or What happens when I’m exposed to a whole bunch.](https://reader035.fdocuments.in/reader035/viewer/2022070400/56649f0e5503460f94c22bb5/html5/thumbnails/10.jpg)
10
Dioxin
Lindane
Methoxychlor
Toxaphene
Endrin
Chlordane
Heptaclor
Ethinylestradiol (EE)
Estrone
Coumestrol
Genistein
Daidzein
Isobutylparaben
Butylparaben
Tim Pastoor, PhD, DABT
![Page 11: Tim Pastoor, PhD, DABT September 10, 2009 Assessing Cumulative Effects of Endocrine Active Substances… or What happens when I’m exposed to a whole bunch.](https://reader035.fdocuments.in/reader035/viewer/2022070400/56649f0e5503460f94c22bb5/html5/thumbnails/11.jpg)
Tim Pastoor, PhD, DABT
September 10, 2009
Sneezing in a Hurricane